Vijaya Diagnostic Centre Limited
NSE: VIJAYA BSE: VIJAYA
Prev Close
1040.7
Open Price
1043
Volume
1,846,084
Today Low / High
1033 / 1112
52 WK Low / High
652.45 / 1275
Range
1,045 - 1,155
Prev Close
1043.55
Open Price
1041.35
Volume
65,692
Today Low / High
1033.25 / 1111.05
52 WK Low / High
653 / 1276.75
Range
1,045 - 1,155
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1100.2 (target range: 1,045 - 1,155), reflecting a change of 59.5 (5.71731%). On the BSE, it is listed at 1100.25 (target range: 1,045 - 1,155), showing a change of 56.7 (5.43338%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Vijaya Diagnostic Centre Limited Graph
Vijaya Diagnostic Centre Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Vijaya Diagnostic Centre Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,100.20, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,100.25 | 1,111.25 | 1,000.13 - 1,222.38 |
| 1,122.26 | 897.80 - 1,346.71 | ||
| 1,133.26 | 793.28 - 1,473.23 | ||
| Bearish Scenario | 1,100.25 | 1,089.25 | 980.32 - 1,198.17 |
| 1,078.25 | 862.60 - 1,293.89 | ||
| 1,067.24 | 747.07 - 1,387.42 |
Overview of Vijaya Diagnostic Centre Limited
ISIN
INE043W01024
Industry
Medical - Diagnostics & Research
Vol.Avg
1,493,201
Market Cap
112,920,435,256
Last Dividend
1
Official Website
IPO Date
2021-09-14
DCF Diff
-255.45
DCF
1,355
Financial Ratios Every Investor Needs
Stock Dividend of VIJAYA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-08-30 | August 30, 24 | 1 | 1 | 2024-08-30 | 2024-10-06 | |
| 2023-09-13 | September 13, 23 | 1 | 1 | 2023-09-13 | 2023-10-20 | |
| 2022-09-20 | September 20, 22 | 1 | 1 | 2022-09-21 | 2022-10-27 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 547.81 Cr | 86.37 Cr | 461.43 Cr | 0.8423 | 0.00 Cr | 91.18 Cr | 362.85 Cr | 118.83 Cr | 11.62 | 239.07 Cr | 0.2169 |
| 2023-03-31 | 459.22 Cr | 58.88 Cr | 400.34 Cr | 0.8718 | 0.00 Cr | 78.93 Cr | 120.31 Cr | 84.63 Cr | 8.29 | 195.66 Cr | 0.1843 |
| 2022-03-31 | 462.11 Cr | 71.50 Cr | 390.61 Cr | 0.8453 | 0.00 Cr | 62.29 Cr | 151.01 Cr | 109.68 Cr | 10.76 | 216.02 Cr | 0.2373 |
| 2021-03-31 | 376.45 Cr | 57.10 Cr | 319.36 Cr | 0.8483 | 0.00 Cr | 48.59 Cr | 115.52 Cr | 84.48 Cr | 8.28 | 177.29 Cr | 0.2244 |
| 2020-03-31 | 338.68 Cr | 43.91 Cr | 294.77 Cr | 0.8704 | 0.00 Cr | 52.68 Cr | 83.45 Cr | 62.54 Cr | 6.13 | 147.98 Cr | 0.1847 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 22.25 Cr | 982.75 Cr | 322.84 Cr | 657.1934 Cr | 259.18 Cr | 236.94 Cr | 5.18 Cr | 610.38 Cr | 0.77 Cr | 0.34 Cr | 0.43 Cr | 72.8659 Cr |
| 2023-03-31 | 24.18 Cr | 853.41 Cr | 306.78 Cr | 544.7294 Cr | 247.56 Cr | 223.38 Cr | 2.05 Cr | 543.48 Cr | 20.35 Cr | 0.46 Cr | 0.44 Cr | 66.1687 Cr |
| 2022-03-31 | 11.05 Cr | 713.46 Cr | 243.92 Cr | 468.2193 Cr | 183.46 Cr | 172.41 Cr | 4.28 Cr | 418.02 Cr | 27.68 Cr | 0.12 Cr | 0.06 Cr | 66.1238 Cr |
| 2021-03-31 | 6.69 Cr | 540.94 Cr | 181.71 Cr | 359.0060 Cr | 141.05 Cr | 134.36 Cr | 2.64 Cr | 273.42 Cr | 7.81 Cr | 0.05 Cr | 5.91 Cr | 43.9880 Cr |
| 2020-03-31 | 55.57 Cr | 482.26 Cr | 208.12 Cr | 274.5430 Cr | 161.23 Cr | 105.66 Cr | 2.77 Cr | 278.60 Cr | 14.17 Cr | 0.12 Cr | 0.04 Cr | 58.6400 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 183.3009 Cr | -142.3073 Cr | -44.5495 Cr | 95.3370 Cr | -1.9292 Cr | 22.2477 Cr | -87.9639 Cr | 118.8253 Cr | 0.0000 Cr | -10.2267 Cr | -2.3042 Cr |
| 2023-03-31 | 164.6117 Cr | -109.5724 Cr | -41.9123 Cr | 39.7691 Cr | 13.1270 Cr | 24.1769 Cr | -124.8426 Cr | 113.5100 Cr | -0.6346 Cr | -10.2111 Cr | 2.2282 Cr |
| 2022-03-31 | 157.9987 Cr | -123.0623 Cr | -30.5721 Cr | 35.6502 Cr | 4.3643 Cr | 11.0499 Cr | -122.3485 Cr | 147.3843 Cr | -3.8368 Cr | 0.0000 Cr | -1.6324 Cr |
| 2021-03-31 | 129.6430 Cr | -129.7570 Cr | -48.7690 Cr | 97.5070 Cr | -48.8830 Cr | 6.6860 Cr | -32.1360 Cr | 112.1240 Cr | -28.3677 Cr | 0.0000 Cr | 0.1290 Cr |
| 2020-03-31 | 106.1120 Cr | -30.6220 Cr | -29.5420 Cr | 58.5650 Cr | 45.9480 Cr | 55.5690 Cr | -47.5470 Cr | 83.4270 Cr | -9.5870 Cr | 0.0000 Cr | -0.5950 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 168.98 Cr | 20.85 Cr | 148.13 Cr | 0.8766 | 48.83 Cr | 35.16 Cr | 3.42 | 71.83 Cr | 0.2080 |
| 2024-09-30 | 182.95 Cr | 22.99 Cr | 159.96 Cr | 0.8743 | 59.15 Cr | 41.94 Cr | 4.09 | 80.49 Cr | 0.2292 |
| 2024-06-30 | 156.22 Cr | 62.75 Cr | 93.47 Cr | 0.5983 | 44.60 Cr | 31.35 Cr | 3.06 | 64.80 Cr | 0.2007 |
| 2024-03-31 | 155.21 Cr | 59.63 Cr | 95.57 Cr | 0.6158 | 46.81 Cr | 33.45 Cr | 3.27 | 63.11 Cr | 0.2155 |
| 2023-12-31 | 132.69 Cr | 15.99 Cr | 116.70 Cr | 0.8795 | 42.87 Cr | 25.85 Cr | 2.53 | 55.37 Cr | 0.1948 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 14.67 Cr | 235.63 Cr | 250.30 Cr | 0.00 Cr | 6.64 Cr | 274.61 Cr | 681.12 Cr | 1,125.30 Cr | 397.35 Cr |
| 2024-06-30 | -182.21 Cr | 364.41 Cr | 182.21 Cr | 0.00 Cr | 0.00 Cr | 182.21 Cr | 0.00 Cr | 0.00 Cr | -659.91 Cr |
| 2024-03-31 | 73.08 Cr | 109.13 Cr | 182.21 Cr | 17.64 Cr | 5.18 Cr | 211.33 Cr | 610.38 Cr | 982.75 Cr | 322.84 Cr |
| 2023-12-31 | -298.17 Cr | 596.33 Cr | 298.17 Cr | 0.00 Cr | 0.00 Cr | 298.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 23.22 Cr | 276.46 Cr | 299.68 Cr | 10.27 Cr | 3.69 Cr | 318.51 Cr | 575.99 Cr | 926.06 Cr | 326.98 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 31.35 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 33.45 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 25.85 Cr | 29.08 Cr | 0.00 Cr | 0.00 Cr | 29.08 Cr | 52.30 Cr | 23.22 Cr | 0.00 Cr | 29.08 Cr |
| 2023-09-30 | 33.32 Cr | 27.38 Cr | 0.00 Cr | 0.00 Cr | 27.38 Cr | 23.22 Cr | -4.15 Cr | 0.00 Cr | 27.38 Cr |
| 2023-06-30 | 26.20 Cr | 24.94 Cr | 0.00 Cr | 0.00 Cr | 24.94 Cr | 49.12 Cr | 24.18 Cr | 0.00 Cr | 24.94 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Diagnostics & Research
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Dr. Lal PathLabs Limited | LALPATHLAB | ₹2,727.20 | ₹227,249,424,399.00 | ₹65,169.00 |
| Vijaya Diagnostic Centre Limited | VIJAYA | ₹1,100.20 | ₹112,920,435,256.00 | ₹1,846,084.00 |
| Metropolis Healthcare Limited | METROPOLIS | ₹1,700.90 | ₹87,224,063,812.00 | ₹80,914.00 |
| Thyrocare Technologies Limited | THYROCARE | ₹731.00 | ₹38,738,211,950.00 | ₹37,171.00 |
| Krsnaa Diagnostics Limited | KRSNAA | ₹809.25 | ₹26,130,490,708.00 | ₹73,440.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: female
Year Born: 1981
Gender: male
Year Born: 1975
Gender: Not Specified
Year Born: 1948
FAQs about Vijaya Diagnostic Centre Limited
The CEO is Ms. Sura Suprita Reddy.
The current price is ₹1,100.20.
The range is ₹652.45-1275.
The market capitalization is ₹11,292.04 crores.
The dividend yield is 0.09%.
The P/E ratio is 79.71.
The company operates in the Healthcare sector.
Overview of Vijaya Diagnostic Centre Limited (ISIN: INE043W01024) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹11,292.04 crores and an average daily volume of 1,493,201 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹1.